Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.7B | 11.2B | 9.4B | 11.6B |
Cost of revenue | 7.5B | 7.9B | 7.3B | 8.3B |
Gross profit | 3.2B | 3.2B | 2.1B | 3.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.1B | 953.2M | 807.1M | 842.9M |
Operating income | 1.5B | 1.7B | 678.3M | 1.8B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 54.5M | 53.0M | 48.2M | 64.3M |
Other income expense | — | — | — | — |
Pretax income | 1.6B | 1.7B | 650.9M | 1.8B |
Tax provision | 422.0M | 514.8M | 161.9M | 574.7M |
Net income | 1.2B | 1.1B | 488.9M | 1.2B |
Basic EPS | — | 4.7 | 2.0 | 5.1 |
Diluted EPS | — | 4.7 | 2.0 | 5.1 |
Basic average shares | — | 241.3M | 240.8M | 241.3M |
Diluted average shares | — | 241.3M | 240.8M | 241.3M |
EBITDA | 1.9B | 2.0B | 996.7M | 2.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |